Unknown

Dataset Information

Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.


ABSTRACT:

Context

Adrenal tumors have a prevalence of around 2% in the general population. Adrenocortical carcinoma (ACC) is rare but accounts for 2-11% of incidentally discovered adrenal masses. Differentiating ACC from adrenocortical adenoma (ACA) represents a diagnostic challenge in patients with adrenal incidentalomas, with tumor size, imaging, and even histology all providing unsatisfactory predictive values.

Objective

Here we developed a novel steroid metabolomic approach, mass spectrometry-based steroid profiling followed by machine learning analysis, and examined its diagnostic value for the detection of adrenal malignancy.

Design

Quantification of 32 distinct adrenal derived steroids was carried out by gas chromatography/mass spectrometry in 24-h urine samples from 102

SUBMITTER: Arlt W 

PROVIDER: S-EPMC3232629 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature